The parents of a teenage girl who died from breast cancer say she would be proud her name is being used in a scheme which might save the lives of other young people.

Her parents say doctors dismissed her symptoms as anxiety or hormone changes because of her age, meaning her cancer went undetected until it was too late.

Isla's Principles is a Scottish government-backed initiative which will be used from now on in all healthcare settings.

Isla first went to see her GP with concerns when she was 14. Her cancer wasn't found until more than two years later and she died six months after that.

She said: "Isla did the right thing. She went, she had a lump. I took her to the doctors, she got referred.

"It got downgraded because she was under16 and we were the ones that went to the doctors over 20 times and at every appointment they said 'no, there's nothing wrong with you'.

"Nobody ever took that extra wee step to say 'wait a minute' so hopefully, moving forward, that never happens again."

Isla's dad Mark added: "Our daughter looked fit and healthy, but she was dying and we didn't know and they didn't know.

"And if there had been some kind of earlier intervention with Isla, the outcome could have been different.

"She maybe would still have cancer, but we think Isla would still have been here. It's bittersweet because obviously our daughter died for this to become a thing. If it saves one family, it's done exactly what we set out to do.

"But hopefully it will help other families. And I think Isla would be really proud that her name is going to help people."

The new guidance makes clear that patients should leave appointments knowing what to expect next and when to seek further help.

Health Secretary Angela Constance said: "My sincere thoughts go out to the Sneddon family over the loss of their daughter, Isla.

"This guidance has been developed to support earlier and more accurate diagnosis of cancers in children and young people.

He said: "Isla's Principles are a reminder of the importance of listening carefully, openly communicating clinical uncertainty, and taking a fresh look when symptoms persist or do not fit the expected pattern."